Skip to content
Longterm Wiki

Kainomyx — Antimalarial Drug (2025)

$900K
Funder
Recipient
Kainomyx
Program
Date
Dec 2024
Data source
Source
Notes

[Scientific Research] Open Philanthropy recommended an investment of $899,999 in Kainomyx to discover and develop novel therapeutics with unique mechanisms of action to treat malaria and other parasitic diseases. If effective, the new drugs would act by inhibiting cytoskeletal proteins in malarial and other parasites. This follows our September 2021 investment and falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing. The grant amount was updated in September 2025.

Other Grants by Coefficient Giving

2625
Showing 10 of 2625 grants
Kainomyx — Antimalarial Drug (2025) | Coefficient Giving | Grants | Longterm Wiki